SpectraBase Spectrum ID |
6X1UEJK5AoL |
Name |
Dormovit 2ME |
Classification |
Pharmaceutical drug derivative |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
278.126657064 u |
Formula |
C14H18N2O4 |
InChI |
InChI=1S/C14H18N2O4/c1-9(2)14(8-10-6-5-7-20-10)11(17)15(3)13(19)16(4)12(14)18/h5-7,9H,8H2,1-4H3 |
InChIKey |
WQXFYLQSGNDCLH-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
278.308 g/mol |
Nominal Mass |
278 u |
Quality |
986 |
Retention Index |
2161 |
SMILES |
C1(C(N(C(N(C1=O)C)=O)C)=O)(CC=1OC=CC1)C(C)C |
SPLASH |
splash10-0019-9250000000-1510863e7f1949c6d325 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
5-(furan-2-ylmethyl)-1,3-dimethyl-5-(propan-2-yl)-1,3-diazinane-2,4,6-trione |
Technique |
GC/MS |
Wiley ID |
DD2024_001243 |